Extracted from this filing and checked against the source text.
Governance Changes
SEC 8-K Item 5.03/5.05/5.06
confidence 0.9
NUVASIVE INC: Adopted exclusive forum bylaw designating Delaware state court (or federal court for District of Delaware) as sole forum for certain actions and federal district courts as sole forum for Securities Act claims (effective 2023-02-08).
- Change
- bylaw amendment
- Effective
- 2023-02-08
Exact text from the filing
On February 8, 2023, the Company’s board of directors approved and adopted “Amendment No. 3 to the Restated Bylaws of NuVasive, Inc.” which adopts an exclusive forum bylaw designating (i) a state court located within the State of Delaware (or, if no state court located within the State of Delaware has jurisdiction, the federal court for the District of Delaware) as the sole and exclusive forum for certain types of actions and proceedings, and (ii) the federal district courts of the United States of America as the sole and exclusive forum for the resolution of any complaint asserting a cause of action arising under the Securities Act of 1933, as amended, against the Company or any director or officer of the Company.
View on SEC.gov
Material Agreements
SEC 8-K Item 1.01/1.02
confidence 0.9
NUVASIVE INC entered into Agreement and Plan of Merger with Globus Medical, Inc. (effective 2023-02-08).
- Action
- entry
- Agreement
- merger
- Counterparty
- Globus Medical, Inc.
- Effective
- 2023-02-08
Exact text from the filing
On February 8, 2023, NuVasive, Inc., a Delaware corporation (“NuVasive” or the “Company”), entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Globus Medical, Inc., a Delaware corporation (“Globus Medical”) and Zebra Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Globus Medical (“Merger Sub”).
View on SEC.gov